H.C. Wainwright says the bar is set for oral GLP-1s following this morning’s type 2 diabetes data from Eli Lilly (LLY). The ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $17.08, a high estimate of ...

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes ...

H.C. Wainwright raised the firm’s price target on Oculis (OCS) to $32 from $29 and keeps a Buy rating on the shares. The firm says the ...

H.C. Wainwright analyst Raghuram Selvaraju raised the firm’s price target on BridgeBio (BBIO) to $53 from $49 and keeps a Buy rating on the ...

Analysts have recently evaluated Verve Therapeutics and provided 12-month price targets. The average target is $17.5, ...

We recently published a list of the 11 Most Promising Penny Stocks According to Analysts. In this article, we are going to ...

The gross proceeds from the, before deducting the placement agent's fees and other offering expenses payable by the Company, ...

Reiterates HC Wainwright & Co.: Buy to Buy 2025-04-11 Reiterates HC Wainwright & Co.: Buy to Buy 2025-02-18 Reiterates HC Wainwright & Co.: Buy to Buy 2024-12-18 Reiterates HC Wainwright & Co.: Buy to ...

We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.